Red cells, anaemia and haemostasis
How red cells are made and destroyed, a working classification of anaemia by cell size and marrow response, the haemolytic anaemias and haemoglobinopathies, and the pathology of bleeding and clotting disorders including disseminated intravascular coagulation and trauma-induced coagulopathy.
By the end of this page you should be able to
- Describe erythropoiesis, its control and the fate of the senescent red cell.
- Classify anaemia by cell size and by reticulocyte response and give the common causes of each group.
- Describe the mechanisms and laboratory features of haemolysis, including the important inherited and acquired causes.
- Describe the pathology of sickle cell disease and thalassaemia.
- Classify bleeding disorders into platelet, coagulation factor and vascular causes, and interpret the screening tests.
- Explain the pathology of disseminated intravascular coagulation and of trauma-induced coagulopathy.
Red cell life and death
Erythropoiesis occurs in the marrow, driven by erythropoietin from renal interstitial cells in response to tissue hypoxia sensed through hypoxia-inducible factor. It needs iron, vitamin B12 and folate as substrates and a functioning marrow. A red cell loses its nucleus and organelles, so it depends on anaerobic glycolysis for energy to run its membrane pumps and on the hexose monophosphate shunt to generate NADPH and keep glutathione reduced against oxidative stress. Its biconcave, deformable membrane, maintained by spectrin and ankyrin, lets it pass through capillaries narrower than itself.
After about 120 days the cell becomes rigid and is removed by splenic macrophages. Haem iron is recycled through transferrin, globin is degraded to amino acids, and the porphyrin ring is converted to unconjugated bilirubin, carried on albumin to the liver for conjugation. Accelerated destruction therefore produces unconjugated hyperbilirubinaemia, a raised lactate dehydrogenase, a low haptoglobin and, when the destruction is intravascular, free haemoglobin in the plasma and urine.
Anaemia is a reduced haemoglobin concentration, not a reduced red cell mass: it can reflect a true deficit or dilution. The physiological responses are a rise in cardiac output, a right shift of the oxygen dissociation curve through increased 2,3-diphosphoglycerate, redistribution of flow, and increased erythropoietin. The symptoms depend as much on the rate of onset as on the final value, which is why a slowly developing severe anaemia can be surprisingly well tolerated.
Classifying anaemia
- Microcytic: iron deficiency (blood loss from gut or uterus, poor intake, malabsorption such as coeliac disease), thalassaemia, anaemia of chronic disease (often normocytic), sideroblastic anaemia and lead poisoning. In iron deficiency, ferritin is low and total iron binding capacity high; in chronic disease ferritin is normal or high because iron is sequestered by hepcidin-driven mechanisms.
- Normocytic: acute blood loss (before dilution), haemolysis, anaemia of chronic disease, chronic kidney disease (low erythropoietin), endocrine disease, and marrow failure or infiltration.
- Macrocytic: megaloblastic (B12 and folate deficiency, where impaired DNA synthesis produces large immature cells, hypersegmented neutrophils and ineffective erythropoiesis) and non-megaloblastic (alcohol, liver disease, hypothyroidism, myelodysplasia, reticulocytosis, drugs such as methotrexate and some antivirals).
- Then ask whether the marrow is responding. A high reticulocyte count means loss or destruction; a low count means production failure. This single question separates bleeding and haemolysis from marrow and substrate problems.
- B12 deficiency deserves separate mention because the neurological consequences, subacute combined degeneration of the dorsal columns and corticospinal tracts, peripheral neuropathy and cognitive change, can occur without anaemia, and can be precipitated by giving folate alone.
Haemolysis
- Where: intravascular (mechanical destruction, complement-mediated, toxins) gives haemoglobinaemia, haemoglobinuria and a risk of acute kidney injury; extravascular (splenic macrophage removal) gives splenomegaly and jaundice without free haemoglobin.
- Inherited membrane defects: hereditary spherocytosis (spectrin and ankyrin defects, so cells are spherical and poorly deformable and are trapped in the spleen; splenomegaly, pigment gallstones, aplastic crisis with parvovirus).
- Inherited enzyme defects: glucose-6-phosphate dehydrogenase deficiency, an X-linked failure to regenerate NADPH, so oxidative stress (infection, fava beans, some sulfonamides and antimalarials) causes episodic haemolysis with Heinz bodies and bite cells; pyruvate kinase deficiency causes chronic haemolysis.
- Haemoglobinopathies: see below.
- Acquired immune: warm autoimmune haemolysis (IgG, spherocytes, extravascular, idiopathic or with lymphoproliferative disease, lupus or drugs), cold agglutinin disease (IgM, complement-mediated, after mycoplasma or Epstein-Barr infection), and alloimmune haemolysis from transfusion or haemolytic disease of the newborn. The direct antiglobulin test is the key investigation.
- Acquired non-immune: microangiopathic haemolysis, where fibrin strands shear red cells, in thrombotic thrombocytopenic purpura (deficient or inhibited ADAMTS13, so ultra-large von Willebrand multimers persist), haemolytic uraemic syndrome (Shiga toxin or complement dysregulation), disseminated intravascular coagulation, malignant hypertension and pre-eclampsia with HELLP syndrome; also mechanical destruction by prosthetic valves, infection (malaria, clostridial sepsis), drugs, burns and envenoming.
Haemoglobinopathies
Sickle cell disease follows a single amino acid substitution in the beta globin chain. Deoxygenated haemoglobin S polymerises, distorting the cell into a rigid sickle shape. Polymerisation is promoted by hypoxia, acidosis, dehydration, cold, infection and stasis, which is also the list of things to correct. The consequences are twofold: chronic haemolysis with pigment gallstones, aplastic crises and a high output state, and vaso-occlusion with painful crises, acute chest syndrome, stroke, splenic sequestration and then autoinfarction with functional asplenia, priapism, avascular necrosis of bone and renal papillary necrosis. Functional asplenia explains the susceptibility to encapsulated organisms and the need for vaccination and prophylaxis. Heterozygotes (sickle trait) are usually asymptomatic except under extreme hypoxic stress, and the trait is protective against falciparum malaria.
Thalassaemia is reduced or absent synthesis of one globin chain, so the chains are imbalanced. Unpaired chains precipitate, damaging the red cell precursor, which produces ineffective erythropoiesis as well as haemolysis. In severe beta thalassaemia, marrow expansion causes skeletal changes and extramedullary haematopoiesis, there is hepatosplenomegaly, and iron overload develops from transfusion and from increased absorption, causing cardiac, hepatic and endocrine damage. The microcytosis is typically disproportionate to the degree of anaemia, with a normal or raised red cell count, which is how it is distinguished from iron deficiency.
Haemostasis and its failure
- Normal haemostasis: vasoconstriction, then a platelet plug (adhesion through von Willebrand factor to collagen, activation, release of ADP and thromboxane, aggregation through glycoprotein IIb/IIIa and fibrinogen), then fibrin generated by the coagulation cascade on the activated platelet surface, then controlled fibrinolysis by plasmin, restrained by antithrombin, proteins C and S and tissue factor pathway inhibitor.
- Platelet and vessel problems cause mucocutaneous bleeding: petechiae, purpura, epistaxis, menorrhagia and immediate bleeding after cuts. Causes: thrombocytopenia (reduced production in marrow disease or alcohol, increased destruction in immune thrombocytopenia, consumption in disseminated intravascular coagulation and microangiopathy, dilution in massive transfusion, splenic pooling), impaired function (drugs, uraemia, von Willebrand disease) and vascular causes (vasculitis, scurvy, steroids, senile purpura, hereditary telangiectasia).
- Coagulation factor problems cause deep bleeding: haemarthrosis, muscle haematoma, retroperitoneal bleeding and delayed bleeding after injury. Causes: haemophilia A and B (X-linked factor VIII and IX deficiency), liver disease (reduced synthesis of most factors, with thrombocytopenia from portal hypertension and abnormal fibrinolysis), vitamin K deficiency (malabsorption, newborn, antibiotics, poor intake, warfarin effect), and acquired inhibitors.
- Interpreting the screen: a prolonged prothrombin time with a normal activated partial thromboplastin time suggests the extrinsic pathway (factor VII, early liver disease or warfarin effect); a prolonged activated partial thromboplastin time alone suggests the intrinsic pathway (factor VIII or IX deficiency, heparin, or a lupus anticoagulant); both prolonged suggests a common pathway problem, severe liver disease, disseminated intravascular coagulation or dilution. Platelet count and fibrinogen must be looked at separately, and a normal screen does not exclude a platelet function disorder or von Willebrand disease.
- Disseminated intravascular coagulation is widespread activation of coagulation by tissue factor exposure, from sepsis, trauma, burns, malignancy, obstetric catastrophe, severe pancreatitis or envenoming. Microthrombi cause organ ischaemia and microangiopathic haemolysis, while consumption of platelets and factors with secondary fibrinolysis causes bleeding, so the patient clots and bleeds at once. The laboratory picture is thrombocytopenia, prolonged times, low fibrinogen and a high D-dimer; treatment is of the cause, with product support guided by bleeding.
- Trauma-induced coagulopathy is distinct and early, driven by tissue injury and shock: activated protein C-mediated anticoagulation, hyperfibrinolysis, platelet dysfunction and fibrinogen depletion, then worsened by the iatrogenic triad of dilution with crystalloid, acidosis and hypothermia, both of which impair enzyme function. This is the rationale for early fibrinogen replacement, balanced blood product resuscitation, antifibrinolytic therapy given early, and keeping the patient warm.
Making the answer flow
- Sort anaemia by cell size, then by reticulocyte count; it turns a huge list into a short one.
- For haemolysis, state where it happens, then the four laboratory findings, then the inherited and acquired causes.
- In sickle cell disease, separate the haemolytic consequences from the vaso-occlusive ones.
- Distinguish platelet-type from factor-type bleeding by the pattern before interpreting any test.
Where marks are lost
- Saying a normal ferritin excludes iron deficiency; it is raised by inflammation.
- Forgetting that B12 deficiency can cause neurological disease without anaemia.
- Treating a normal coagulation screen as proof of normal haemostasis.
- Describing disseminated intravascular coagulation as purely a bleeding disorder.
- Attributing early trauma coagulopathy only to dilution, when it begins before any fluid is given.
Where this meets the emergency department
- Fibrinogen falls first in major haemorrhage, and hypothermia and acidosis stop the clotting enzymes working, so warming the patient is part of treating the coagulopathy.
- A normal coagulation screen does not exclude a bleeding disorder: von Willebrand disease and platelet dysfunction do not show up on it.
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
How would you classify anaemia?
Show answer
- By mean cell volume: microcytic, normocytic, macrocytic, each with a short causal list.
- By marrow response: reticulocytosis indicates loss or destruction, a low count indicates production failure.
- By mechanism: blood loss, haemolysis, reduced production, dilution.
- Supporting tests: film, iron studies, B12 and folate, haemolysis screen, renal and thyroid function.
- 2.
What are the laboratory features of haemolysis?
Show answer
- Raised unconjugated bilirubin and lactate dehydrogenase, low haptoglobin, reticulocytosis.
- Film: spherocytes, fragments, sickle cells, bite cells and Heinz bodies according to cause.
- Intravascular haemolysis adds haemoglobinaemia and haemoglobinuria, with acute kidney injury risk.
- Direct antiglobulin test positive in immune causes.
- 3.
Describe the pathophysiology of sickle cell disease.
Show answer
- Point mutation in beta globin; deoxyhaemoglobin S polymerises and distorts the cell.
- Promoted by hypoxia, acidosis, dehydration, cold, infection and stasis.
- Chronic haemolysis: jaundice, pigment gallstones, aplastic crisis with parvovirus, high output state.
- Vaso-occlusion: painful crisis, acute chest syndrome, stroke, splenic sequestration then autoinfarction, priapism, avascular necrosis, papillary necrosis.
- Functional asplenia gives susceptibility to encapsulated organisms.
- 4.
How does thalassaemia differ from iron deficiency?
Show answer
- Thalassaemia: imbalanced globin synthesis, precipitation of unpaired chains, ineffective erythropoiesis and haemolysis.
- Microcytosis is disproportionate to the anaemia, with a normal or raised red cell count and normal or high ferritin.
- Iron deficiency: low ferritin, raised iron binding capacity, low reticulocyte count, often with an identifiable source of loss.
- Confirmation by haemoglobin electrophoresis or high performance liquid chromatography.
- 5.
A patient bleeds easily. How does the pattern help you?
Show answer
- Mucocutaneous bleeding with petechiae and immediate oozing suggests a platelet or vascular problem.
- Deep bleeding into joints and muscles with delayed bleeding suggests a factor deficiency.
- Lifelong history suggests inherited disease; recent onset suggests acquired disease or a drug.
- Examination for splenomegaly, lymphadenopathy, liver disease and purpura distribution.
- 6.
How do you interpret a prolonged activated partial thromboplastin time?
Show answer
- Intrinsic or common pathway problem: factor VIII, IX, XI or XII deficiency; heparin; lupus anticoagulant; severe liver disease.
- Mixing study: correction suggests deficiency, failure to correct suggests an inhibitor.
- Normal prothrombin time narrows it to the intrinsic pathway.
- Remember a lupus anticoagulant prolongs the test but predisposes to thrombosis, not bleeding.
- 7.
Describe disseminated intravascular coagulation.
Show answer
- Widespread tissue factor-driven activation of coagulation with microthrombi and consumption of platelets and factors.
- Causes: sepsis, major trauma, burns, malignancy, obstetric emergencies, pancreatitis, envenoming.
- Simultaneous thrombosis and bleeding, with microangiopathic haemolysis and organ failure.
- Laboratory: thrombocytopenia, prolonged times, low fibrinogen, high D-dimer.
- Treat the cause; give product support guided by bleeding rather than by numbers alone.
- 8.
What is trauma-induced coagulopathy and why does it matter?
Show answer
- Early endogenous coagulopathy from tissue injury and shock: activated protein C-mediated anticoagulation, hyperfibrinolysis, platelet dysfunction, fibrinogen depletion.
- Present before fluid is given, then worsened by dilution, acidosis and hypothermia.
- Fibrinogen falls first in major haemorrhage, so it is measured and replaced early.
- Management principles: balanced product resuscitation, early antifibrinolytic therapy, warming, limiting crystalloid, and rapid haemorrhage control.
Practise this week
Week 13 in the other subjects
- Anatomy: Thoracic wall, pleura and lungs
- Pharmacology: Neuromuscular blockers and reversal
- Physiology: Ventilation, dead space and V/Q matching
Not affiliated with the Australasian College for Emergency Medicine. Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.